The evolution of resistant Candida species in cancer centers - Implications for treatment and prophylaxis

被引：12
作者：
Riddell, James [1 ]
Kauffman, Carol A. [1 ,2 ]
机构：
[1] Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA
[2] Vet Affairs Ann Arbor Healthcare Syst, Div Infect Dis, Ann Arbor, MI USA
来源：
CANCER | 2008年 / 112卷 / 11期
关键词：
D O I：
10.1002/cncr.23465
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2334 / 2337
页数：4
相关论文
共 23 条
[1]   The epidemiology of hematogenous candidiasis caused by different Candida species [J].
AbiSaid, D ;
Anaissie, E ;
Uzun, O ;
Raad, I ;
Pinzcowski, H ;
Vartivarian, S .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1122-1128
[2]   Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Winston, Drew J. ;
Perfect, John ;
Ullmann, Andrew J. ;
Walsh, Thomas J. ;
Helfgott, David ;
Holowiecki, Jerzy ;
Stockelberg, Dick ;
Goh, Yeow-Tee ;
Petrini, Mario ;
Hardalo, Cathy ;
Suresh, Ramachandran ;
Angulo-Gonzalez, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359
[3]   Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study [J].
Diekema, DJ ;
Messer, SA ;
Brueggemann, AB ;
Coffman, SL ;
Doern, GV ;
Herwaldt, LA ;
Pfaller, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1298-1302
[4]   Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study [J].
Garey, Kevin W. ;
Rege, Milind ;
Pai, Manjunath P. ;
Mingo, Dana E. ;
Suda, Katie J. ;
Turpin, Robin S. ;
Bearden, David T. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) :25-31
[5]  
Gerberding J, 1999, AM J INFECT CONTROL, V27, P520
[6]   Attributable mortality of nosocomial candidemia, revisited [J].
Gudlaugsson, O ;
Gillespie, S ;
Lee, K ;
Berg, JV ;
Hu, JF ;
Messer, S ;
Herwaldt, L ;
Pfaller, M ;
Diekema, D .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :1172-1177
[7]   The changing epidemiology of invasive Candidiasis - Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy [J].
Hachem, Ray ;
Hanna, Hend ;
Kontoyiannis, Dimitrios ;
Jiang, Ying ;
Raad, Issam .
CANCER, 2008, 112 (11) :2493-2499
[8]   Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia:: a case-case-control study [J].
Lin, MY ;
Carmeli, Y ;
Zumsteg, J ;
Flores, EL ;
Tolentino, J ;
Sreeramoju, P ;
Weber, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4555-4560
[9]   Triazole cross-resistance among candida spp.: Case report, occurrence among bloodstream isolates, and implications for antifungal therapy [J].
Magill, SS ;
Shields, C ;
Sears, CL ;
Choti, M ;
Merz, WG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) :529-535
[10]   Candida glabrata fungemia:: Experience in a tertiary care center [J].
Malani, A ;
Hmoud, J ;
Chiu, L ;
Carver, PL ;
Bielaczyc, A ;
Kauffman, CA .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (07) :975-981
123